These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 7640209)

  • 41. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
    Ades S; Maxfield LF; Gould CJ; Jones GK; Levy SB
    Int J Oncol; 2006 Mar; 28(3):747-53. PubMed ID: 16465381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
    Barrand MA; Bagrij T; Neo SY
    Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP.
    Germann UA; Ford PJ; Shlyakhter D; Mason VS; Harding MW
    Anticancer Drugs; 1997 Feb; 8(2):141-55. PubMed ID: 9073310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug concentration-dependent expression of multidrug resistance-associated protein and P-glycoprotein in the doxorubicin-resistant acute myelogenous leukemia sublines.
    Choi CH; Kim HS; Rha HS; Jeong JH; Park YH; Min YD; Kee KH; Lim DY
    Mol Cells; 1999 Jun; 9(3):314-9. PubMed ID: 10420992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
    Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
    Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells.
    Abe T; Hasegawa S; Taniguchi K; Yokomizo A; Kuwano T; Ono M; Mori T; Hori S; Kohno K; Kuwano M
    Int J Cancer; 1994 Sep; 58(6):860-4. PubMed ID: 7927879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multidrug resistance-associated protein (MRP) gene expression in human lung cancer.
    Narasaki F; Matsuo I; Ikuno N; Fukuda M; Soda H; Oka M
    Anticancer Res; 1996; 16(4A):2079-82. PubMed ID: 8712746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Reversal of nomegestrol acetate on multidrug resistance in drug-resistant human breast cancer cell line MCF7/ADR].
    Li J; Xu L; He K; Guo W; Zhu X; Zheng Y; Xia P
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):129-32. PubMed ID: 12015032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.
    Tews DS; Nissen A; Külgen C; Gaumann AK
    J Neurooncol; 2000 Dec; 50(3):227-37. PubMed ID: 11263502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
    den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ
    Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
    Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
    Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidrug resistance-associated protein gene expression and drug sensitivity in human lung cancer cells.
    Narasaki F; Oka M; Fukuda M; Ikeda K; Terashi K; Takatani H; Nakamura T; Soda H; Kohno S
    Anticancer Res; 1997; 17(5A):3493-7. PubMed ID: 9413193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Establishment of new multidrug-resistant human osteosarcoma cell lines.
    Oda Y; Matsumoto Y; Harimaya K; Iwamoto Y; Tsuneyoshi M
    Oncol Rep; 2000; 7(4):859-66. PubMed ID: 10854558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells.
    Ichihashi N; Kitajima Y
    Br J Dermatol; 2001 Apr; 144(4):745-50. PubMed ID: 11298532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
    Schuurhuis GJ; Broxterman HJ; Ossenkoppele GJ; Baak JP; Eekman CA; Kuiper CM; Feller N; van Heijningen TH; Klumper E; Pieters R
    Clin Cancer Res; 1995 Jan; 1(1):81-93. PubMed ID: 9815890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase.
    Rappa G; Lorico A; Liu MC; Kruh GD; Cory AH; Cory JG; Sartorelli AC
    Biochem Pharmacol; 1997 Sep; 54(6):649-55. PubMed ID: 9310341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.
    Hirata S; Katoh O; Oguri T; Watanabe H; Yajin K
    Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
    Giaccone G; van Ark-Otte J; Rubio GJ; Gazdar AF; Broxterman HJ; Dingemans AM; Flens MJ; Scheper RJ; Pinedo HM
    Int J Cancer; 1996 Jun; 66(6):760-7. PubMed ID: 8647646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
    Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
    Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.